“The Illusion of Thinking”: Implications for HealthcareBy Vikas Chowdhry
Vikas Chowdhry, MS, MBA is founder and CEO of TraumaCare.ai.
If you are even moderately interested in AI, I am sure you have by…
Continue Reading
Jaideep Tandon, MS is co-founder and CEO of Infinx.
Tell me about yourself and the company.
I come from a technology background in engineering, with a focus on doing back office work over…
Jeff Beck, Founder and CEO of AnswersNow
Autism acceptance differs from awareness in that acceptance reinforces the need for inclusion—an acknowledgement that neurodiversity can be a strength and that people with autism are valued, contributing members of society.
This…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Dr. George Magrath, CEO at Opus Genetics, practicing ophthalmologist, and someone who’s…
Continue Reading
Ivor Campbell, CEO at Snedden Campbell
Separate conversations with a couple of friends recently led me to a rather shocking conclusion about the provision of healthcare in the UK today.
One friend was bemoaning the experience…
Continue Reading
Sami Inkinen, co-founder and CEO of Virta Health
On the heels of Weight Watchers’ recent bankruptcy filing, the conversation around the future of the weight loss industry has intensified. While many point to the rise…
Continue Reading
MedTech Innovator is an accelerator that works with large companies to invest in, support and scale healthcare technology companies. Its partners include Johnson & Johnson, the American Heart Association, and others. MedTech has graduated…
Continue Reading
Mayo Clinic in Florida is exploring the potential for ambient clinical intelligence to enable a more proactive approach to care delivery, and potentially reduce hospitalizations and severity of illness and improve patient quality of life.WHY…
Continue Reading
Viraj Narayanan, CEO at Cornerstone AI
Daniel Lane, Head of RWD Strategy & Operations at Bristol Myers Squibb
Real-world data (RWD) has become the pharmaceutical industry’s most promising yet challenging frontier. While companies have long…
Continue Reading
Pangea Data, a company focused on detecting rare diseases in patients, is partnering with Alexion, a subsidiary of AstraZeneca focused on treating rare diseases, to co-develop, clinically validate and ultimately seek regulatory approval for…
Continue Reading
